The development of combination therapy involving camptothecins: a review of preclinical and early clinical studies

Cancer Treat Rev. 1998 Jun;24(3):205-20. doi: 10.1016/s0305-7372(98)90050-0.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antimetabolites, Antineoplastic / administration & dosage
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents, Alkylating / administration & dosage
  • Antineoplastic Agents, Phytogenic / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Camptothecin / administration & dosage
  • Camptothecin / analogs & derivatives
  • Cisplatin / administration & dosage
  • Clinical Trials, Phase I as Topic
  • Clinical Trials, Phase II as Topic
  • Drug Screening Assays, Antitumor
  • Enzyme Inhibitors / administration & dosage
  • Humans
  • Irinotecan
  • Paclitaxel / administration & dosage
  • Topoisomerase I Inhibitors
  • Topotecan / administration & dosage

Substances

  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents
  • Antineoplastic Agents, Alkylating
  • Antineoplastic Agents, Phytogenic
  • Enzyme Inhibitors
  • Topoisomerase I Inhibitors
  • Irinotecan
  • Topotecan
  • Paclitaxel
  • Cisplatin
  • Camptothecin